Bamco Inc. NY Increases Stake in Tempus AI, Inc.

Institutional investor raises holdings in AI healthcare company by over 50%

Mar. 16, 2026 at 8:19am

Got story updates? Submit your updates here. ›

Bamco Inc. NY, an institutional investor, has increased its stake in Tempus AI, Inc. (NASDAQ:TEM) by 53.7% in the third quarter, according to a recent SEC filing. The investor now owns 263,250 shares of the AI-driven healthcare company, worth approximately $21.2 million.

Why it matters

Tempus AI is a fast-growing healthcare technology company that applies artificial intelligence and machine learning to clinical and molecular data to advance precision medicine, particularly in oncology. The increase in Bamco's stake suggests confidence in Tempus AI's technology and business model among institutional investors.

The details

According to the filing, Bamco Inc. NY added 92,007 shares to its existing position in Tempus AI during the third quarter. The investor now owns about 0.15% of the company's outstanding shares. Several other hedge funds and institutional investors have also increased their holdings in Tempus AI in recent quarters, including Vanguard Group, BNP Paribas Financial Markets, and AQR Capital Management.

  • Bamco Inc. NY increased its stake in Tempus AI during the third quarter of 2026.

The players

Bamco Inc. NY

An institutional investor that has increased its stake in Tempus AI, Inc.

Tempus AI, Inc.

An AI-driven healthcare company that applies machine learning to clinical and molecular data to advance precision medicine.

Got photos? Submit your photos here. ›

The takeaway

The increase in Bamco's stake in Tempus AI suggests that institutional investors see significant potential in the company's AI-powered healthcare technology and its ability to drive innovation in precision medicine.